QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 12, 2004, 24(19):4692-4697; doi:10.1523/JNEUROSCI.0277-04.2004

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (25) Citing Articles via Google Scholar Google Scholar Articles by Chin, J. Articles by Mucke, L. Search for Related Content PubMed PubMed Citation Articles by Chin, J. Articles by Mucke, L.

 Previous Article  |  Next Article 

Neurobiology of Disease
Fyn Kinase Modulates Synaptotoxicity, But Not Aberrant Sprouting, in Human Amyloid Precursor Protein Transgenic Mice

Jeannie Chin,¹ Jorge J. Palop,¹ Gui-Qiu Yu,¹ Nobuhiko Kojima,² Eliezer Masliah,³ and Lennart Mucke¹

¹Gladstone Institute of Neurological Disease and Department of Neurology, University of California, San Francisco, California 94141, ²Neuronal Circuit Mechanisms Research Group, RIKEN Brain Science Institute, Wako 351-0198, Japan, and ³Departments of Neurosciences and Pathology, University of California at San Diego, La Jolla, California 92093

Alzheimer's disease (AD), the most common neurodegenerative disorder, results in progressive degeneration of synapses and aberrant sprouting of axon terminals. The mechanisms underlying these seemingly opposing cellular phenomena are unclear. We hypothesized that Fyn kinase may play a role in one or both of these processes because it is increased in AD brains and because it is involved in synaptic plasticity and axonal outgrowth. We investigated the effects of Fyn on AD-related synaptotoxicity and aberrant axonal sprouting by ablating or overexpressing Fyn in human amyloid precursor protein (hAPP) transgenic mice.

On the fyn^+/+ background, hAPP/amyloid peptide (A) decreased hippocampal levels of synaptophysin-immunoreactive presynaptic terminals (SIPTs), consistent with previous findings. On the fyn^-/- background, hAPP/A did not affect SIPTs. SIPT reductions correlated with hippocampal A levels in hAPP/fyn^+/+, but not hAPP/fyn^-/-, mice suggesting that Fyn provides a critical link between hAPP/A and SIPTs. Furthermore, overexpression of Fyn exacerbated SIPT reductions in hAPP mice. We also found that the susceptibility of mice to hAPP/A-induced premature mortality was decreased by Fyn ablation and increased by Fyn overexpression. In contrast, axonal sprouting in the hippocampus of hAPP mice was unaffected. We conclude that Fyn-dependent pathways are critical in AD-related synaptotoxicity and that the pathogenesis of hAPP/A-induced neuronal alterations may be mechanistically heterogenous.

Key words: Alzheimer's disease; amyloid ; Fyn kinase; synaptic deficits; signaling; sprouting; GAP-43; neurodegeneration

---

Received Jan 23, 2004; revised April 8, 2004; accepted April 9, 2004.

This article has been cited by other articles:

				T. G. Bengoechea, Z. Chen, D. A. O'Leary, E. Masliah, and K.-F. Lee p75 reduces {beta}-amyloid-induced sympathetic innervation deficits in an Alzheimer's disease mouse model PNAS, May 12, 2009; 106(19): 7870 - 7875. [Abstract] [Full Text] [PDF]

				R. Minkeviciene, S. Rheims, M. B. Dobszay, M. Zilberter, J. Hartikainen, L. Fulop, B. Penke, Y. Zilberter, T. Harkany, A. Pitkanen, et al. Amyloid {beta}-Induced Neuronal Hyperexcitability Triggers Progressive Epilepsy J. Neurosci., March 18, 2009; 29(11): 3453 - 3462. [Abstract] [Full Text] [PDF]

				S. D. Buckingham, A. K. Jones, L. A. Brown, and D. B. Sattelle Nicotinic Acetylcholine Receptor Signalling: Roles in Alzheimer's Disease and Amyloid Neuroprotection Pharmacol. Rev., March 1, 2009; 61(1): 39 - 61. [Abstract] [Full Text] [PDF]

				W. J. Meilandt, G.-Q. Yu, J. Chin, E. D. Roberson, J. J. Palop, T. Wu, K. Scearce-Levie, and L. Mucke Enkephalin Elevations Contribute to Neuronal and Behavioral Impairments in a Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., May 7, 2008; 28(19): 5007 - 5017. [Abstract] [Full Text] [PDF]

				R. Williamson, A. Usardi, D. P. Hanger, and B. H. Anderton Membrane-bound {beta}-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism FASEB J, May 1, 2008; 22(5): 1552 - 1559. [Abstract] [Full Text] [PDF]

				H.-S. Hoe, S. S. Minami, A. Makarova, J. Lee, B. T. Hyman, Y. Matsuoka, and G. W. Rebeck Fyn Modulation of Dab1 Effects on Amyloid Precursor Protein and ApoE Receptor 2 Processing J. Biol. Chem., March 7, 2008; 283(10): 6288 - 6299. [Abstract] [Full Text] [PDF]

				D. V. Venkitaramani, J. Chin, W. J. Netzer, G. K. Gouras, S. Lesne, R. Malinow, and P. J. Lombroso {beta}-Amyloid Modulation of Synaptic Transmission and Plasticity J. Neurosci., October 31, 2007; 27(44): 11832 - 11837. [Full Text] [PDF]

				I. H. Cheng, K. Scearce-Levie, J. Legleiter, J. J. Palop, H. Gerstein, N. Bien-Ly, J. Puolivali, S. Lesne, K. H. Ashe, P. J. Muchowski, et al. Accelerating Amyloid-beta Fibrillization Reduces Oligomer Levels and Functional Deficits in Alzheimer Disease Mouse Models J. Biol. Chem., August 17, 2007; 282(33): 23818 - 23828. [Abstract] [Full Text] [PDF]

				E. D. Roberson, K. Scearce-Levie, J. J. Palop, F. Yan, I. H. Cheng, T. Wu, H. Gerstein, G.-Q. Yu, and L. Mucke Reducing Endogenous Tau Ameliorates Amyloid {beta}-Induced Deficits in an Alzheimer's Disease Mouse Model Science, May 4, 2007; 316(5825): 750 - 754. [Abstract] [Full Text] [PDF]

				V. M. Sharma, J. M. Litersky, K. Bhaskar, and G. Lee Tau impacts on growth-factor-stimulated actin remodeling J. Cell Sci., March 1, 2007; 120(5): 748 - 757. [Abstract] [Full Text] [PDF]

				J. Mojsilovic-Petrovic, G.-B. Jeong, A. Crocker, A. Arneja, S. David, D. Russell, and R. G. Kalb Protecting Motor Neurons from Toxic Insult by Antagonism of Adenosine A2a and Trk Receptors J. Neurosci., September 6, 2006; 26(36): 9250 - 9263. [Abstract] [Full Text] [PDF]

				K. Bhaskar, S.-H. Yen, and G. Lee Disease-related Modifications in Tau Affect the Interaction between Fyn and Tau J. Biol. Chem., October 21, 2005; 280(42): 35119 - 35125. [Abstract] [Full Text] [PDF]

				J. Chin, J. J. Palop, J. Puolivali, C. Massaro, N. Bien-Ly, H. Gerstein, K. Scearce-Levie, E. Masliah, and L. Mucke Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease J. Neurosci., October 19, 2005; 25(42): 9694 - 9703. [Abstract] [Full Text] [PDF]

				G. P. Lim, F. Calon, T. Morihara, F. Yang, B. Teter, O. Ubeda, N. Salem Jr, S. A. Frautschy, and G. M. Cole A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model J. Neurosci., March 23, 2005; 25(12): 3032 - 3040. [Abstract] [Full Text] [PDF]

				P. N. Lacor, M. C. Buniel, L. Chang, S. J. Fernandez, Y. Gong, K. L. Viola, M. P. Lambert, P. T. Velasco, E. H. Bigio, C. E. Finch, et al. Synaptic Targeting by Alzheimer's-Related Amyloid {beta} Oligomers J. Neurosci., November 10, 2004; 24(45): 10191 - 10200. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help